In summary, our study demonstrated that the BDNF-AS/miR-125a/b-5p/Bcl-2 axis was closely associated with the progression of MM, suggesting that this axis might be a potential diagnostic and therapeutic target for MM. Here, BCL2 is linked to Miyoshi myopathy.